These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7908485)

  • 1. Dithranol (anthralin) and 10-butyryl dithranol (butantrone) do not morphologically transform cultured C3H 10T1/2 C18 mouse embryo fibroblasts.
    Viluksela M; Debets FM; van der Hoeven JC; Männistö PT
    Acta Derm Venereol; 1994 Jan; 74(1):54-6. PubMed ID: 7908485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the contact sensitizing activity of dithranol (anthralin) and 10-butyryl dithranol (butantrone).
    Viluksela M; Haasio K; Männistö PT
    Contact Dermatitis; 1990 Aug; 23(2):103-10. PubMed ID: 2209005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice.
    Viluksela M; Puotunen E; Newman AJ; Männistö PT
    Carcinogenesis; 1986 Oct; 7(10):1755-60. PubMed ID: 3757176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation of HeLa cells by dithranol (anthralin) and 1o-butyryl dithranol (butantrone).
    Remitz A; Kariniemi AL; Lehtonen E; Nordling S
    Br J Dermatol; 1989 Apr; 120(4):525-31. PubMed ID: 2730843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice.
    Männistö PT; Vaissi L; Mustakallio KK; Viluksela M; Kosma VM; Collan Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):255-60. PubMed ID: 6423812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H; Mustakallio KK
    Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of soybean lipoxygenase-1 by 10-butyryl substituted 1,8-dihydroxy-9-anthrone (butantrone).
    Laakso S; Römer L; Mustakallio KK
    Med Biol; 1986; 64(1):43-5. PubMed ID: 3088340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological studies with dithranol and its 10-acyl analogues.
    Männistö PT; Kirkland D; Viluksela M; Tikkanen L
    Arch Toxicol; 1986 Oct; 59(3):180-5. PubMed ID: 3813885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles.
    Patierno SR; Banh D; Landolph JR
    Cancer Res; 1988 Sep; 48(18):5280-8. PubMed ID: 3409252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin irritation by dithranol (anthralin) and its 10-acyl analogues in 3 animal models.
    Männistö P; Havas A; Haasio K; Hanhijärvi H; Mustakallio K
    Contact Dermatitis; 1984 Mar; 10(3):140-5. PubMed ID: 6232099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells.
    Patierno SR; Lehman NL; Henderson BE; Landolph JR
    Cancer Res; 1989 Feb; 49(4):1038-44. PubMed ID: 2912548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds.
    Miura T; Patierno SR; Sakuramoto T; Landolph JR
    Environ Mol Mutagen; 1989; 14(2):65-78. PubMed ID: 2548861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible expression of morphological transformation in C3H/10T1/2 mouse embryo cultures exposed to 12-O-tetradecanoylphorbol-13-acetate.
    Sanchez JH; Abernethy DJ; Boreiko CJ
    Carcinogenesis; 1986 Nov; 7(11):1793-6. PubMed ID: 3769129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
    Bertram JS
    Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic transformation of C3H/10T1/2 Cl 8 mouse embryo fibroblasts by inhibitors of nucleotide metabolism.
    Peterson AR; Heidelberger C; Benedict WF
    Basic Life Sci; 1985; 31():465-79. PubMed ID: 3158305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month dermal toxicity test with dithranol and butantrone in miniature swine.
    Männistö PT; Hanhijärvi H; Kosma VM; Collan Y
    Contact Dermatitis; 1986 Jul; 15(1):1-9. PubMed ID: 2944694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.